Table A1.
Treatment/Intervention | Administered n | Positive Response | Negative Response | No Response |
---|---|---|---|---|
SSRI—fluvoxamine | 5 | 3 “Symptoms improved” “Moderate improvement” “Significantly better” |
0 | 2 “No improvement” “No change” |
Amantadine | 2 | 2 “Partial improvement” “Partial improvement” |
||
Levomepromazine | 2 | 2 “Partial improvement” “Partial improvement” |
||
Haloperidol | 4 | 3 “Improvement” “Partially improved” “Improvement for 6 months” |
1 “Unsuccessful” |
|
Mexazolam | 1 | 1 “Improvement” |
||
Bromazepam | 1 | 1 “Partial improvement” |
||
Carbamazepine | 2 | 1 “Partial improvement” |
1 “Unsuccessful” |
|
Clomipramine | 4 | 3 “Partial improvement” “Partial improvement” “Complete recovery” “Slight improvement, side effects” |
||
Romethazine | 1 | 1 “Partial improvement” |
||
Lorazepam | 10 | 4 “Partial improvement” “80% return to baseline” “Responded to” “Showed increase” “Significant improvement” |
1 “Negative effects” |
5 “No consistent improvement” “No consistent improvement” “No consistent improvement” “No change” “Ineffective” |
Methylprednisolon | 3 | 3 “Dramatic improvement” “Immediate improvement” “Many behaviours resolved” |
||
IVIG | 4 | 4 “Full recovery” “Steady improvement” “Lots of symptoms resolved” “Resolution of everything except insomnia” |
||
Mycephenolate | 1 | 1 Discontinued no data |
||
Oral steroid | 2 | 2 “Immediate improvement” “Lots of resolved symptoms” |
||
Rituximab | 1 | 1 “Improvement” |
||
Electro-convulsive therapy | 10 | 10 “Some behaviours completely resolved” “Complete recovery” “Complete recovery” “Complete recovery” “Complete recovery” “Robust response” “Significant improvement” “Return to almost baseline” “Excellent response” Strong response” |
||
Benzodiazepines | 1 | 1 “Partial improvement” |
||
Anti depressants | 1 | 1 “Steady return to baseline” |
||
Positive airway pressure for obstructive sleep apnoea | 1 | 1 “Steady return to baseline” |
||
Psychological support | 2 | 2 “Steady return to baseline” “Moderate improvement for 6 months” |
||
Donepezil | 1 | 1 “Return to baseline” |
||
Acetylcholinesterase inhibitor | 1 | 1 “Return to baseline” |
||
Bupropion | 1 | 1 “Worsening of catatonia and further decline” |
||
Trazodone | 4 | 1 “Some improvement” |
2 “Worsening of catatonia and further decline” “Worsening and decline” |
1 “Unsuccessful” |
Olanzapine | 1 | 1 “Worsening of catatonia and further decline” |
||
Aripiprazole | 1 | 1 “Worsening of catatonia and further decline” |
||
Ziprasidone | 1 | 1 “Worsening of catatonia and further decline” |
||
Lithium | 3 | 1 “Improvement” |
1 “Worsening of catatonia and further decline” |
1 “No improvement” |
Clozapine | 1 | 1 “85% return to baseline” |
||
Desipramine | 6 | 1 “Moderate improvement for 6 months” |
1 “Worsening of symptoms” |
4 “No change” “No effect” “Unsuccessful” “Unsuccessful” |
Thiothixine | 2 | 1 “Complete recovery” |
1 “No change” |
|
Amitriptyline | 1 | 1 “Complete recovery” |
||
Nortriptyline | 1 | 1 “Unsuccessful” |
||
Clonazepam | 2 | 1 “Partial improvement” |
1 “Unsuccessful” |
|
Ethosuximide | 1 | 1 “No effect” |
||
Lidexamfetamine | 1 | 1 “Worsening” |
||
SSRI citalopram | 1 | 1 “Worsening” |
||
Amiloride | 1 | 1 “Improvement” |
||
Lamotrigine | 1 | 1 “No effect” |
||
Antipsychotic treatment | 1 | 1 “Good response” |
Note: dosages and additional medications/treatments are not reported.